Complete genome assemblies and antibiograms of 22 Staphylococcus capitis isolates

doi:10.21203/rs.3.rs-4808318/v1

Download PDF

Data Note

Complete genome assemblies and antibiograms of 22 Staphylococcus capitis isolates

https://doi.org/10.21203/rs.3.rs-4808318/v1

This work is licensed under a CC BY 4.0 License

You are reading this latest preprint version

Objective

Staphylococcus capitis is part of the human microbiome and an opportunistic pathogen known to cause catheter-associated bacteraemia, prosthetic joint infections, skin and wound infections, among others. Detection of S. capitis in normally sterile body sites saw an increase over the last decade in England, where a multidrug-resistant clone, NRCS-A, was widely identified in blood samples from infants in neonatal intensive care units. To address a lack of complete genomes and antibiograms of S. capitis in public databases, we performed long- and short-read whole-genome sequencing, hybrid genome assembly, and antimicrobial susceptibility testing of 22 diverse isolates.

Data description

We present complete genome assemblies of two S. capitis type strains (subspecies capitis: DSM 20326; subspecies urealyticus: DSM 6717) and 20 clinical isolates (NRCS-A: 10) from England. Each genome is accompanied by minimum inhibitory concentrations of 13 antimicrobials including vancomycin, teicoplanin, daptomycin, linezolid, and clindamycin. These 22 genomes were 2.4–2.7 Mbp in length and had a GC content of 33%. Plasmids were identified in 20 isolates. Resistance to teicoplanin, daptomycin, gentamicin, fusidic acid, rifampicin, ciprofloxacin, clindamycin, and erythromycin was seen in 1–10 isolates. Our data are a resource for future studies on genomics, evolution, and antimicrobial resistance of S. capitis.

Staphylococcus capitis

reference genomes

hybrid genome assembly

antimicrobial susceptibility

antimicrobial resistance

antibiograms

bioresource

genomics

NRCS-A clone

Nanopore MinION sequencing

Staphylococcus capitis, consisting of two subspecies capitis and urealyticus [1, 2], is a coagulase-negative opportunistic pathogen commonly causing late-onset sepsis (LOS) in very-low-birthweight infants in neonatal intensive care units (NICUs) and various infections in adults, such as prosthetic joint infections [3, 4]. A multidrug-resistant clone of S. capitis subsp. urealyticus, NRCS-A, has emerged as a global concern in neonatal health for its dominance in LOS, reduced susceptibility to vancomycin, enhanced biofilm-forming ability, increased disinfectant and desiccation tolerance, association with neonatal incubators, and persistence in NICUs [5–7]. Between 2020 and 2021, the UK Health Security Agency (UKHSA) convened a nationwide investigation into increased reporting of neonatal S. capitis bacteraemia in England [8] and requested voluntary referral of clinical isolates from diagnostic laboratories for whole-genome sequencing (WGS). Genomic epidemiological analysis of the WGS data revealed widespread presence of the NRCS-A clone in neonatal units across the country, highlighting the need to further understand genomics, antimicrobial resistance (AMR), and niche adaptation of this clone in comparison with other S. capitis subpopulations [9].

In this report, we describe complete genome assemblies and accompanying antibiograms of 22 S. capitis isolates consisting of 20 English clinical isolates and type strains of the two subspecies (capitis: DSM 20326; urealyticus: DSM 6717). The clinical isolates were selected from UKHSA’s culture collection to represent the main S. capitis subpopulations previously identified (Figure S1) [9], with 19 of these isolates recovered from normally sterile sites in patients across England. Readers are referred to Table S1 for source information of isolates. Altogether, 10 NRCS-A isolates and 12 non-NRCS-A isolates were sequenced. Our work addresses the lack of finished-grade S. capitis reference genomes and antibiograms in the National Center for Biotechnology Information (NCBI) databases, providing a bioresource for future studies on the genomics, AMR, molecular epidemiology, and evolution of S. capitis.

Each isolate was incubated on Columbia agar with horse blood (PB0122A, Thermo Scientific, UK) at 37°C overnight for DNA extraction and antimicrobial susceptibility testing in 2021 (Batch 1, 19 isolates) or 2023 (Batch 2, three isolates) (Table S2). For Batch 1, genomic DNA of each isolate was extracted using GeneJET Genomic DNA Purification Kits (Thermo Scientific). Long-read WGS was conducted with Oxford Nanopore Technologies (ONT, UK) MinION R9.4.1 flow-cells (FLO-MIN106D) and Rapid Barcoding Kits (SQK-RBK004). High-accuracy basecalling was performed with guppy (ONT). Short-read sequencing of the same DNA was performed on Illumina HiSeq 2500 systems at the UKHSA following an in-house 2×101 bp protocol. For Batch 2, genomic DNA was extracted using a Wizard Genomic DNA Purification Kit (Promega, USA). Long-read WGS was conducted with an ONT MinION R10.4.1 flow-cell (FLO-MIN114) and Rapid Barcoding Kit 24 V14 (SQK-RBK114.24). Super-accuracy basecalling was performed using guppy. Short-read sequencing of the same DNA was performed under a 2×251 bp layout on Illumina NovaSeq 6000 systems at MicrobesNG (UK). Susceptibility of isolates to 13 antimicrobials was determined by the UKHSA Antimicrobial Resistance and Healthcare Associated Infections Reference Unit with gradient strips (Liofilchem, Italy, for Batch 1) or broth microdilution (EUSTAPF, Thermo Scientific, for Batch 2) following European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines (Batch 1, v11.0; Batch 2, v13.1). Inducible clindamycin resistance was sought by testing for the antagonism between erythromycin and clindamycin (D-test).

ONT reads were trimmed with fastp and filtered with nanoq for quality control [10, 11]. Illumina reads were trimmed and filtered with fastp [12]. Hybrid de novo genome assembly was performed with an ONT-reads-first strategy using Flye, Raven, and minipolish as implemented in Trycycler [13–16] or only using Raven, according to estimated read depths. Alternatively, an Illumina-reads-first strategy was applied using Unicycler when a genome could not be fully assembled from ONT reads [17, 18]. All assemblies were polished with ONT reads using medaka (github.com/nanoporetech/medaka) followed by Illumina-read polishing using Polypolish and POLCA [19, 20]. Polished assemblies were then were reoriented to start from dnaA (chromosomes) or repA (plasmids) genes using dnaapler [21]. Reoriented assemblies were polished with Illumina reads using Polypolish, assessed using Quast and CheckM2 [22, 23], and annotated with the NCBI Prokaryotic Genome Annotation Pipeline [24].

Twenty-two complete genome assemblies were generated, with the same GC content of 33% and lengths of 2.4–2.7 Mbp (Table S2). One to four plasmids (2.3–69 kbp) were identified in 20 isolates (NRCS-A: 9; non-NRCS-A: 11). The NRCS-A clone exhibited reduced susceptibility to teicoplanin, daptomycin, and gentamicin (Table S3). Resistance to fusidic acid (MICs: 16–32 mg/L), erythromycin (MIC > 256 mg/L), and clindamycin (MIC > 256 mg/L or inducible) was seen in 9/22 (41%), 7/22 (32%), and 5/22 (23%) of isolates, respectively, with no significant frequency difference between NRCS-A and non-NRCS-A isolates (p-value = 1, Fisher’s exact test). One NRCS-A isolate exhibited rifampicin resistance (MIC > 32 mg/L). All isolates were susceptible to vancomycin, linezolid, and quinupristin-dalfopristin, and seven non-NRCS-A isolates, including the two type strains, were susceptible to all 11 antimicrobials having EUCAST breakpoints.

Table 1

Overview of datafiles/datasets
Label	Name of data file/data set	File types (file extension)	Data repository and identifier (DOI or accession number)
Datafile 1	Figure S1, Genetic relatedness between the 22 selected isolates within the context of 838 isolates previously analysed	Portable Document Format file (.pdf)	figshare, DOI: 10.6084/m9.figshare.26048464 [25]
Datafile 2	Table S1, sources and data accessions of S. capitis isolates	MS Excel file (.xlsx)	figshare, DOI: 10.6084/m9.figshare.26049013 [26]
Datafile 3	Table S2, methods and summary statistics of genome assemblies	MS Excel file (.xlsx)	figshare, DOI: 10.6084/m9.figshare.26049070 [27]
Datafile 4	Table S3, antibiograms of isolates	MS Excel file (.xlsx)	figshare, DOI: 10.6084/m9.figshare.26049094 [28]
Dataset 1	Illumina and ONT reads, and annotated genome assemblies	SRA (.sra) and GenBank files (.gbk)	NCBI BioProject PRJNA1032276 [29]

This dataset is limited to a small sample size (n = 22), which does not capture all major phenotypic and genetic variations in S. capitis. The isolates are limited to England and dominated by invasive isolates (n = 19) recovered from normally sterile body sites of humans — eight (42%) invasive isolates were collected from infants of ≤ 90 days of age, one (5%) from an infant between > 90 days and < 1 year of age, two (10%) from children between six and 11 years of age, and eight from adults (≥ 18 years of age). Moreover, antimicrobial susceptibility of all isolates in Batch 1 (n = 19) was not determined using the gold-standard method, broth microdilution. Future work needs to elucidate mechanisms of AMR [30] and include a wider range of isolates, such as those recovered from carriage screening, environments, animals, and other health-related samples from non-clinical settings.

AMR Antimicrobial resistance

BRC Biomedical Research Centre

DSM Deutsche Sammlung von Mikroorganismen

EUCAST European Committee on Antimicrobial Susceptibility Testing

HPRU Health Protection Research Unit

LOS Late-onset sepsis

NCBI National Center for Biotechnology Information

NICU Neonatal intensive care unit

NIHR National Institute for Health Research

ONT Oxford Nanopore Technologies

WGS Whole-genome sequencing

UKHSA UK Health Security Agency

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Availability of data and materials

Data generated in this study are listed in Table 1. Specifically, sequence data and antibiograms have been deposited in NCBI databases under the BioProject accession PRJNA1032276. Antibiograms are accessible in BioSample records of the isolates.

Competing interests

The authors declare no completing interests.

Funding

This work was mainly funded by the UKHSA and partially funded by the Wellcome Trust and Imperial College London through Y. Wan’s Imperial Institutional Strategic Support Fund Springboard Research Fellowship (grant number: PSN109). Y. Wan is a David Price Evans Research Fellow in Global Health and Infectious Diseases, funded by the University of Liverpool. Professor A. H. Holmes is a National Institute for Health and Care Research (NIHR) Senior Investigator and is affiliated with the Department of Health and Social Care funded Centre for Antimicrobial Optimisation at Imperial College London. Y. Wan, D. Meunier, M. Getino, E. Jauneikaite, A. H. Holmes, C. S. Brown, A. Demirjian, K. L. Hopkins, and B. Pichon are affiliated with the National Institute for Health and Care Research Health Protection Research Unit (NIHR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at Imperial College London in partnership with the UKHSA, in collaboration with, Imperial Healthcare Partners, University of Cambridge and University of Warwick (grant number: NIHR200876). The views expressed in this article are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health and Social Care.

Authors’ contributions

Conceptualisation: Y. Wan, B. Pichon; resources: B. Pichon, K. L. Hopkins, J. Coelho, E. Jauneikaite, K. Moganeradj; investigation: Y. Wan, R. Pike, A. Harley, Z. Mumin, I. Potterill, D. Meunier, M. Ganner, M. Getino, K. L. Hopkins; supervision: B. Pichon, K. L. Hopkins, J. Coelho, A. Demirjian, C. S. Brown, A. H. Holmes, E. Jauneikaite, K. Moganeradj; funding acquisition: C. S. Brown, Y. Wan, A. H. Holmes, E. Jauneikaite. Writing, first draft: Y. Wan; editing: Y. Wan, D. Meunier, R. Pike, E. Jauneikaite, A. Demirjian, C. S. Brown, B. Pichon, K. L. Hopkins, K. Moganeradj, M. Ganner; approval of the final manuscript: All.

Acknowledgements

All authors thank microbiology laboratories and clinicians across the UK for sharing S. capitis isolates and specimen information. Illumina WGS of isolates in Batch 1 was carried out by the Colindale Sequencing Laboratory at the UKHSA. Part of the microbiological work, sample preparation, ONT sequencing, and bioinformatics analysis was undertaken at the Colebrook Laboratory, a facility supported by the NIHR Imperial Biomedical Research Centre (BRC). Part of bioinformatics analysis was performed on equipment purchased as part of MRC CARP fellowship award MR/T005254/1.

Kloos WE, Schleifer KH. Isolation and Characterization of Staphylococci from Human Skin II. Descriptions of Four New Species: Staphylococcus warneri, Staphylococcus capitis, Staphylococcus hominis, and Staphylococcus simulans 1. International Journal of Systematic and Evolutionary Microbiology. 1975;25:62–79.
Bannerman TL, Kloos WE. Staphylococcus capitis subsp. ureolyticus subsp. nov. from Human Skin. International Journal of Systematic and Evolutionary Microbiology. 1991;41:144–7.
Butin M, Martins-Simões P, Rasigade J-P, Picaud J-C, Laurent F. Worldwide Endemicity of a Multidrug-Resistant Staphylococcus capitis Clone Involved in Neonatal Sepsis. Emerg Infect Dis. 2017;23:538–9.
Tevell S, Baig S, Hellmark B, Martins Simoes P, Wirth T, Butin M, et al. Presence of the neonatal Staphylococcus capitis outbreak clone (NRCS-A) in prosthetic joint infections. Sci Rep. 2020;10:22389.
Rasigade J-P, Raulin O, Picaud J-C, Tellini C, Bes M, Grando J, et al. Methicillin-Resistant Staphylococcus capitis with Reduced Vancomycin Susceptibility Causes Late-Onset Sepsis in Intensive Care Neonates. PLoS ONE. 2012;7:e31548.
Chavignon M, Coignet L, Bonhomme M, Bergot M, Tristan A, Verhoeven P, et al. Environmental Persistence of Staphylococcus capitis NRCS-A in Neonatal Intensive Care Units: Role of Biofilm Formation, Desiccation, and Disinfectant Tolerance. Microbiol Spectr. 2022;10:e04215–22.
Moore G, Barry A, Carter J, Ready J, Wan Y, Elsayed M, et al. Detection, survival, and persistence of Staphylococcus capitis NRCS-A in neonatal units in England. J Hosp Infect. 2023;140:8–14.
Paranthaman K, Wilson A, Verlander N, Rooney G, Macdonald N, Nsonwu O, et al. Trends in coagulase-negative staphylococci (CoNS), England, 2010–2021. Access Microbiol. 2023;5:000491v3.
Wan Y, Ganner M, Mumin Z, Ready D, Moore G, Potterill I, et al. Whole-genome sequencing reveals widespread presence of Staphylococcus capitis NRCS-A clone in neonatal units across the United Kingdom. J Infect. 2023;87:210–9.
Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884–90.
Steinig E, Coin L. Nanoq: ultra-fast quality control for nanopore reads. J Open Source Softw. 2022;7:2991.
Andrews S. FastQC: A quality control tool for high throughput sequence data. 2010.
Kolmogorov M, Yuan J, Lin Y, Pevzner PA. Assembly of long, error-prone reads using repeat graphs. Nat Biotechnol. 2019;37:540–6.
Vaser R, Šikić M. Time- and memory-efficient genome assembly with Raven. Nat Comput Sci. 2021;1:332–6.
Wick RR, Holt KE. Benchmarking of long-read assemblers for prokaryote whole genome sequencing. F1000Research; 2021.
Wick RR, Judd LM, Cerdeira LT, Hawkey J, Méric G, Vezina B, et al. Trycycler: consensus long-read assemblies for bacterial genomes. Genome Biol. 2021;22:266.
Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19:455–77.
Wick RR, Judd LM, Gorrie CL, Holt KE. Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol. 2017;13:e1005595.
Wick RR, Holt KE, Polypolish. Short-read polishing of long-read bacterial genome assemblies. PLoS Comput Biol. 2022;18:e1009802.
Zimin AV, Salzberg SL. The genome polishing tool POLCA makes fast and accurate corrections in genome assemblies. PLoS Comput Biol. 2020;16:e1007981.
Bouras G, Grigson SR, Papudeshi B, Mallawaarachchi V, Roach MJ. Dnaapler: A tool to reorient circular microbial genomes. J Open Source Softw. 2024;9:5968.
Gurevich A, Saveliev V, Vyahhi N, Tesler G. QUAST: quality assessment tool for genome assemblies. Bioinformatics. 2013;29:1072–5.
Chklovski A, Parks DH, Woodcroft BJ, Tyson GW. CheckM2: a rapid, scalable and accurate tool for assessing microbial genome quality using machine learning. Nat Methods. 2023;20:1203–12.
Tatusova T, DiCuccio M, Badretdin A, Chetvernin V, Nawrocki EP, Zaslavsky L, et al. NCBI prokaryotic genome annotation pipeline. Nucleic Acids Res. 2016;44:6614–24.
Wan Y, Ganner M, Pike R, Mumin Z, Potterill I, Meunier D et al. Figure S1, genetic relatedness between the 22 selected isolates within the context of 838 isolates previously analysed. 2024. https://doi.org/10.6084/m9.figshare.26048464
Wan Y, Ganner M, Pike R, Mumin Z, Potterill I, Meunier D et al. Table S1, sources and data accessions of S. capitis isolates. 2024. https://doi.org/10.6084/m9.figshare.26049013
Wan Y, Ganner M, Pike R, Mumin Z, Potterill I, Meunier D et al. Table S2, methods and summary statistics of genome assemblies. 2024. https://doi.org/10.6084/m9.figshare.26049070
Wan Y, Ganner M, Pike R, Mumin Z, Potterill I, Meunier D et al. Table S3, antibiograms of isolates. 2024. https://doi.org/10.6084/m9.figshare.26049094
Wan Y, Ganner M, Pike R, Mumin Z, Potterill I, Meunier D et al. Staphylococcus capitis reference genomes. 2024. https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1032276
Chindelevitch L, van Dongen M, Graz H, Pedrotta A, Suresh A, Uplekar S, et al. Ten simple rules for the sharing of bacterial genotype—Phenotype data on antimicrobial resistance. PLoS Comput Biol. 2023;19:e1011129.

No competing interests reported.

Download PDF

Reviews received at journal
23 Aug, 2024
Reviewers agreed at journal
21 Aug, 2024
Reviewers invited by journal
20 Aug, 2024
Editor assigned by journal
31 Jul, 2024
Submission checks completed at journal
31 Jul, 2024
First submitted to journal
26 Jul, 2024

You are reading this latest preprint version

Complete genome assemblies and antibiograms of 22 Staphylococcus capitis isolates

Status:

Version 1

Abstract

Objective

Data description

Objective

Data description

Limitations

Abbreviations

Declarations

Ethics approval and consent to participate

Consent for publication

Availability of data and materials

Competing interests

Funding

Authors’ contributions

Acknowledgements

References

Additional Declarations

Supplementary Files

Status:

Version 1